Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
InVitro Capital is a venture studio founded to build and fund innovative companies from the ground up, with a strong emphasis on transforming overlooked markets into AI-powered ventures. Established in Orange County, California, the firm has expanded its operations to include hubs in Boston, Mexico City, Cairo, and Panama City. This geographical diversity allows InVitro Capital to tap into various markets across North America, Latin America, Europe, and Asia, enhancing its ability to identify and nurture promising startups.
The firm specializes in de-risking the startup-building process, employing a methodical approach to create scalable and profitable companies. By focusing on labor-intensive and fragmented industries that are often under-innovated, InVitro Capital aims to leverage disruptive technologies, particularly in sectors such as HealthTech, FinTech, AdTech, and HRTech. The firm covers a wide range of funding stages, from seed rounds to growth equity, ensuring that it can support companies at various points in their development.
InVitro Capital's reputation in the startup ecosystem is bolstered by its commitment to fostering innovation and its strategic focus on AI and SaaS solutions. The firm is dedicated to building a robust portfolio of companies that not only succeed but also contribute positively to their respective industries.
InVitro Capital's investment focus is centered on labor-intensive, fragmented industries that are often overlooked and under-innovated. The firm actively seeks opportunities in sectors such as HealthTech, FinTech, AdTech, HRTech, and SaaS, where it believes disruptive technologies can create significant value. By investing in these areas, InVitro Capital aims to support the development of scalable business models that leverage artificial intelligence and software as a service.
The firm is particularly interested in companies that are addressing inefficiencies within their industries, providing innovative solutions that enhance productivity and improve service delivery. InVitro Capital covers a broad spectrum of funding stages, from seed investments to growth equity, allowing it to engage with startups at various levels of maturity. This flexibility enables the firm to adapt its support to the specific needs of each company, fostering their growth and success.
InVitro Capital looks for founders who are passionate about their vision and are committed to driving change within their industries. The firm values innovative thinking and a strong execution strategy, believing that these qualities are essential for building successful, AI-driven ventures. By focusing on these criteria, InVitro Capital aims to create a portfolio of companies that not only thrive but also lead their sectors in innovation and growth.
InVitro Capital boasts a notable portfolio of companies that exemplify its investment thesis and commitment to innovation. Among its standout investments is **Curenta**, an AI-powered platform that revolutionizes assisted living facilities by providing smart compliance tools and intelligent medication management. This innovative solution addresses critical challenges in the healthcare sector, enhancing the quality of care for residents.
Another significant portfolio company is **Östa**, which merges advanced AI and augmented reality with skilled craftsmanship to improve handyman, electrical, HVAC, and plumbing services. This integration of technology into traditional trades exemplifies InVitro Capital's focus on transforming labor-intensive industries.
**AllCare** is also part of InVitro's portfolio, offering primary care services delivered directly to assisted living facilities throughout Southern California. This model not only improves access to healthcare but also streamlines care coordination for residents.
Additionally, **AllRx** represents InVitro Capital's commitment to innovation in the pharmacy sector, providing on-demand prescription delivery services across Southern California. This service addresses the growing demand for convenience in healthcare, showcasing the firm's ability to identify and invest in companies that meet evolving consumer needs.
InVitro Capital operates a venture studio program that focuses on building and funding AI-powered companies. This program is designed to support startups from the idea stage through to exit, providing resources and guidance to navigate the startup ecosystem effectively. Founders interested in participating in this program should reach out directly to InVitro Capital for more information on how to apply and what the program entails.
InVitro Capital invests in companies at various stages, from seed rounds to growth equity. This flexibility allows them to support startups as they develop and scale their operations.
Founders interested in pitching to InVitro Capital should prepare a comprehensive presentation that outlines their business model, market opportunity, and how their solution leverages AI or SaaS technologies. While specific submission guidelines are not provided, a clear and compelling pitch is essential.
InVitro Capital primarily focuses on sectors such as HealthTech, FinTech, AdTech, HRTech, and SaaS. They target labor-intensive and fragmented industries that are under-innovated, seeking to invest in companies that can disrupt these markets.
The specific check sizes for investments by InVitro Capital are not detailed in the available information. However, they cover funding stages from seed to growth equity, indicating a range of investment amounts depending on the stage and needs of the company.
InVitro Capital has a broad geographical focus, investing in North America, Latin America, Europe, and Asia. This diverse presence allows them to tap into various markets and identify unique opportunities.
The application process details for InVitro Capital are not explicitly mentioned. However, founders are encouraged to present their business ideas and demonstrate how they align with the firm's investment focus on AI-driven solutions.
While specific details on portfolio support are not provided, InVitro Capital's venture studio model suggests that they likely offer strategic guidance and resources to help their portfolio companies grow and succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.